☆ 4.6 Article

Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Surgery

Use of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities

Elizabeth J. Klein et al.

Summary: It has been shown that passive immunization with anti-spike monoclonal antibodies (mAbs) may greatly benefit organ transplant recipients in mounting an immune response to COVID-19. The study found that mAb therapy significantly decreased hospitalizations or emergency room visits among kidney transplant recipients with COVID-19, with potential disparities in treatment access and outcomes based on patient race and ethnicity.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Article Immunology

Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study

Rebecca N. Kumar et al.

Summary: A retrospective case-control study found that treatment with bamlanivimab was associated with a lower 30-day hospitalization rate in high-risk ambulatory patients with COVID-19.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021

Jennifer L. Wiltz et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Medicine, General & Internal

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial

Robert L. Gottlieb et al.

Summary: The study showed that treatment with bamlanivimab and etesevimab was significantly associated with a reduction in SARS-CoV-2 viral load at day 11 in nonhospitalized patients with mild to moderate COVID-19, compared to placebo. However, bamlanivimab monotherapy did not show a significant reduction in viral load. Ongoing clinical trials will focus on assessing the clinical benefits of antispike neutralizing antibodies in COVID-19 patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Geriatrics & Gerontology

A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities

Sidna Tulledge-Scheitel et al.

Summary: In response to the increased risk of severe COVID-19 in nursing home residents, a mobile monoclonal antibody infusion program was implemented to quickly treat high-risk patients in skilled nursing facilities, resulting in a low event rate of 11.1% within 14 days post-infusion. Further studies are needed to explore the scalability and efficacy of this program.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

Add to Collection

Article Medicine, General & Internal

Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 US Cities An Ecological Study

Usama Bilal et al.

Summary: The study revealed spatial inequities in COVID-19 testing, positivity, confirmed cases, and mortality in three cities of New York, Philadelphia, and Chicago. High and low clusters of positivity, confirmed cases, and mortality were found to be co-located with clusters of low and high social vulnerability. Neighborhoods with higher social vulnerability had lower testing rates and higher positivity ratios, confirmed case rates, and mortality rates.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Immunology

Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

J. Ryan Bariola et al.

Summary: The study found that bamlanivimab monoclonal antibody monotherapy significantly reduced the risk of hospitalization and mortality among high-risk COVID-19 outpatients.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Critical Care Medicine

A Novel Approach to Equitable Distribution of Scarce Therapeutics Institutional Experience Implementing a Reserve System for Allocation of COVID-19 Monoclonal Antibodies

Emily Rubin et al.

Summary: The study aimed to investigate the successful deployment of a reserve system in a large health system to promote equitable access to mAb therapy among socially vulnerable patients. Despite operational challenges, the reserve system effectively increased the number of socially vulnerable patients offered and received mAb therapy.

CHEST (2021)

Add to Collection

Letter Health Care Sciences & Services

Uptake of Outpatient Monoclonal Antibody Treatments for COVID-19 in the United States: a Cross-Sectional Analysis

Timothy S. Anderson et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage

Paula Yoon et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Immunology

Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States

Kaitlin Rainwater-Lovett et al.

Summary: In a diverse real-world COVID-19 patient population, mAb treatment significantly decreased the risk of subsequent ED visit or hospitalization, showing potential to reduce the burden on hospitals. Broader use of mAbs, especially in disadvantaged patient populations, should be promoted in the United States to ensure health equity.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, Research & Experimental

Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19

Ravindra Ganesh et al.

Summary: Bamlanivimab treatment in high-risk patients with mild to moderate COVID-19 was associated with significantly lower rates of hospitalization, ICU admission, and mortality compared to usual care.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Medicine, General & Internal

COVID-19 exacerbating inequalities in the US

Aaron van Dorn et al.

LANCET (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Association Between Social Vulnerability and a County's Risk for Becoming a COVID-19 Hotspot - United States, June 1-July 25, 2020

Sharoda Dasgupta et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Social Vulnerability and Racial Inequality in COVID-19 Deaths in Chicago

Sage J. Kim et al.

HEALTH EDUCATION & BEHAVIOR (2020)

Add to Collection

Article Computer Science, Interdisciplinary Applications

The REDCap consortium: Building an international community of software platform partners

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2019)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

Add to Collection

Article Genetics & Heredity

What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era

FS Collins

NATURE GENETICS (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.